Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Zoolog Sci ; 38(4): 305-310, 2021 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-34342950

RESUMO

To clarify the molecular mechanism of prevention of entry into diapause in Bombyx mori by HCl treatment, we biochemically analyzed calcineurin regulatory B subunit (CNB) in diapause eggs treated with HCl solution. Our previous studies revealed that HCl treatment causes Ca2+ to efflux from diapause eggs. Therefore, we attempted to analyze CNB, which is known to associate with Ca2+. The gene expression level of CNB was increased by HCl treatment and the changes of the gene expression were almost the same as that in the non-diapause eggs. As for diapause eggs, almost no gene expression of CNB was confirmed except just after oviposition. In the assay for phosphorylation by protein kinase CK2, recombinant CNB (rCNB) was phosphorylated in vitro. Additionally, a Ca2+ binding assay indicated that rCNB shows affinity for Ca2+. The distribution of CNB was investigated with an immunohistochemical technique using antiserum against rCNB in diapause eggs and HCl-treated diapause eggs. CNB was localized in serosa cells and yolk cells in both eggs. These data may suggest that CNB is activated by intracellular Ca2+ or efflux Ca2+ resulting from HCl treatment, and that it plays a role in the molecular mechanisms of artificial diapause prevention or the breaking of diapause in the silkworm.


Assuntos
Bombyx/fisiologia , Calcineurina/metabolismo , Diapausa , Proteínas de Insetos/metabolismo , Subunidades Proteicas/metabolismo , Animais , Bombyx/efeitos dos fármacos , Bombyx/genética , Calcineurina/química , Calcineurina/genética , Cálcio/metabolismo , Diapausa/efeitos dos fármacos , Regulação da Expressão Gênica , Ácido Clorídrico/farmacologia , Imuno-Histoquímica , Proteínas de Insetos/química , Proteínas de Insetos/genética , Óvulo/metabolismo , Fosforilação , Análise Serial de Proteínas , Subunidades Proteicas/química , Subunidades Proteicas/genética , Distribuição Tecidual
2.
Biomed Res ; 31(4): 231-7, 2010 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-20834180

RESUMO

Hericium erinaceus, a well known edible mushroom, has numerous biological activities. Especially hericenones and erinacines isolated from its fruiting body stimulate nerve growth factor (NGF) synthesis, which expects H. erinaceus to have some effects on brain functions and autonomic nervous system. Herein, we investigated the clinical effects of H. erinaceus on menopause, depression, sleep quality and indefinite complaints, using the Kupperman Menopausal Index (KMI), the Center for Epidemiologic Studies Depression Scale (CES-D), the Pittsburgh Sleep Quality Index (PSQI), and the Indefinite Complaints Index (ICI). Thirty females were randomly assigned to either the H. erinaceus (HE) group or the placebo group and took HE cookies or placebo cookies for 4 weeks. Each of the CES-D and the ICI score after the HE intake was significantly lower than that before. In two terms of the ICI, "insentive" and "palpitatio", each of the mean score of the HE group was significantly lower than the placebo group. "Concentration", "irritating" and "anxious" tended to be lower than the placebo group. Our results show that HE intake has the possibility to reduce depression and anxiety and these results suggest a different mechanism from NGF-enhancing action of H. erinaceus.


Assuntos
Agaricales/química , Ansiedade/tratamento farmacológico , Depressão/tratamento farmacológico , Fator de Crescimento Neural/biossíntese , Adulto , Método Duplo-Cego , Esquema de Medicação , Feminino , Humanos , Menopausa/efeitos dos fármacos , Pessoa de Meia-Idade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA